Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Riad Abès

Showing results (1-10 of 6) with videos related to

Pageof 1
Sort By:
Cancer Metastasis Reviews|January 27, 2011
Modulation of tumor immunity by therapeutic monoclonal antibodiesRiad Abès, Jean-Luc Teillaud
Pharmaceuticals (Basel, Switzerland)|October 8, 2016
Impact of Glycosylation on Effector Functions of Therapeutic IgGRiad Abès, Jean-Luc Teillaud
Medecine Sciences : M/S|December 29, 2009
[Antibodies: better knowledge for a better use]Riad Abès, Charles-Antoine Dutertre, Jean-Luc Teillaud
Blood|May 5, 2010
Long-lasting antitumor protection by anti-CD20 antibody through cellular immune responseRiad Abès, Emmanuelle Gélizé, Wolf Herman Fridman, et al.
Expert Review of Clinical Immunology|May 19, 2010
Activating and inhibitory Fcgamma receptors in immunotherapy: being the actor or being the targetRiad Abès, Charles-Antoine Dutertre, Lauren Agnelli, et al.
Journal of Immunology (Baltimore, Md. : 1950)|February 3, 2023
First-in-Human Study in Healthy Subjects with the Noncytotoxic Monoclonal Antibody OSE-127, a Strict Antagonist of IL-7RαNicolas Poirier, Irène Baccelli, Lyssia Belarif, et al.
Pageof 1

Showing results (1-10 of 6) with videos related to

Sort By:
Pageof 1
Cancer Metastasis Reviews|January 27, 2011
Modulation of tumor immunity by therapeutic monoclonal antibodiesRiad Abès, Jean-Luc Teillaud
Pharmaceuticals (Basel, Switzerland)|October 8, 2016
Impact of Glycosylation on Effector Functions of Therapeutic IgGRiad Abès, Jean-Luc Teillaud
Medecine Sciences : M/S|December 29, 2009
[Antibodies: better knowledge for a better use]Riad Abès, Charles-Antoine Dutertre, Jean-Luc Teillaud
Blood|May 5, 2010
Long-lasting antitumor protection by anti-CD20 antibody through cellular immune responseRiad Abès, Emmanuelle Gélizé, Wolf Herman Fridman, et al.
Expert Review of Clinical Immunology|May 19, 2010
Activating and inhibitory Fcgamma receptors in immunotherapy: being the actor or being the targetRiad Abès, Charles-Antoine Dutertre, Lauren Agnelli, et al.
Journal of Immunology (Baltimore, Md. : 1950)|February 3, 2023
First-in-Human Study in Healthy Subjects with the Noncytotoxic Monoclonal Antibody OSE-127, a Strict Antagonist of IL-7RαNicolas Poirier, Irène Baccelli, Lyssia Belarif, et al.
Pageof 1